Novo Nordisk (NVO) plans to launch its blockbuster weight-loss drug Wegovy in vial format. The move targets customers who have shifted to rival Eli Lilly & Co. (LLY).
This packaging change follows Eli Lilly’s lead in offering similar options for obesity treatments. Novo Nordisk currently distributes Wegovy exclusively through plastic injector pens.
The update aims to broaden accessibility and boost competitiveness in the growing market for weight management drugs.
Timm Hanly's Dramatic TransformationTimm Hanly, the 31-year-old former star of The Bachelorette, has revealed a strikingly different appearance that has…
Major Canadian Bank Backs New Global Security InstitutionScotiabank has become the second major Canadian financial institution to support a new…
Unfulfilled Promises and Paper Accomplishments Raise Questions Recent examinations of Prime Minister Mark Carney's administration reveal a pattern of ambitious…
Investment OverviewFortinet (FTNT) shares have risen by just 9% since early August, trailing the company's strong business performance over the…
